Last reviewed · How we verify

ICG-guided bowel perfusion assessment

Leiden University Medical Center · Phase 3 active Small molecule

ICG (indocyanine green) fluorescence imaging enables real-time visualization of bowel perfusion during surgery to assess tissue viability and prevent anastomotic complications.

ICG (indocyanine green) fluorescence imaging enables real-time visualization of bowel perfusion during surgery to assess tissue viability and prevent anastomotic complications. Used for Intraoperative assessment of bowel perfusion during colorectal surgery, Prevention of anastomotic complications in gastrointestinal surgery.

At a glance

Generic nameICG-guided bowel perfusion assessment
SponsorLeiden University Medical Center
Drug classSurgical imaging agent
ModalitySmall molecule
Therapeutic areaSurgery / Gastroenterology
PhasePhase 3

Mechanism of action

ICG is a near-infrared fluorescent dye that binds to plasma proteins and is rapidly taken up by well-perfused tissue. When excited by near-infrared light, it emits fluorescence that can be detected intraoperatively, allowing surgeons to visualize blood flow in bowel segments in real-time. This helps identify areas of compromised perfusion that may be at risk for anastomotic leak or other ischemic complications.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: